logo

Verastem, Inc. (VSTM)



Trade VSTM now with
  Date
  Headline
10/23/2019 7:44:00 AM Verastem Oncology Announces COPIKTRA Presentations At Lymphoma & Myeloma 2019 International Congress
10/7/2019 7:03:09 AM Yakult Doses First Patient In Phase 1b Japanese Bridging Study Of COPIKTRA In Patients With R/R CLL/SLL
10/4/2019 7:05:38 AM Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7/3/2019 7:08:24 AM Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6/20/2019 7:07:39 AM Verastem Oncology: Robert Forrester To Step Down As President And CEO
2/20/2019 7:17:04 AM Verastem Announces Several Key Appointments To Its Management Team
12/4/2018 7:08:00 AM Verastem Presents Duvelisib Development Program Data At American Society Of Hematology 2018 Annual Meeting
10/9/2018 7:08:39 AM NCCN Adds Verastem Oncology’s COPIKTRA Capsules To Clinical Practice Guidelines In Oncology
10/8/2018 7:12:40 AM NCCN Adds Verastem Oncology’s COPIKTRA Capsules To Clinical Practice Guidelines In Oncology
9/6/2018 7:08:06 AM Verastem Oncology Announces Investigator Sponsored Study On Duvelisib In Combination With Venetoclax
8/29/2018 4:09:24 PM Verastem Oncology Appoints Robert Gagnon As CFO
6/16/2018 6:41:36 AM Verastem Oncology Presents Duvelisib Data At EHA 2018 Annual Meeting
6/14/2018 4:04:03 PM Verastem Oncology Announces $43 Mln Offering Of Common Stock
5/16/2018 9:30:32 AM Verastem Oncology Announces Pricing Of Public Offering Of 7.78 Mln Shares At $4.50/Shr
  
 
>